Exchange: NASDAQ·Updated 09:07 PM EST
TXG logo

TXG 10x Genomics Inc - Ordinary Shares - Class A

$71.51
$11.44
(14.03%)
Today
Closed $70.11
$1.40
(2.00%)
Overnight
EarningsNov 5
Mkt Cap$9.13B
Vol5.22M

About TXG

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
33

Bearish Sentiment

How do you feel about TXG?

PensionPulse
$TXG Druckenmiller made a killing off this stock. I'm keeping an eye on it for a reversal but definitely not rushing in, going to nibble when it goes green...
1
1
Dr_Stoxx
$TXG and genome plays: they all priced in the bubonic plague...and today whacked as it turns out to have been fake news. $ARKG $XBI $IBB
3
cfromhertz
$TXG resolving higher after decent consolidation around 50d MA note, $TXG was one of my Focus Charts headed into the week :
2
yesitrade
$TXG Sooo fortunate today. Predetermined sell order got filled pre-market (for my whopping 83 shares) @ 98.64. Wow. (I have a habit of trying to catch the proverbial "falling knife", so I'm going to let this play out for a couple days and see how it goes...)
2
Guadangia
$TXG I suffered from vertigo so sold my last TXG 20% block past Friday, so 100% out with 5-20% exits at 58, 67, 72, 82 and 94. My media was $13 so this is been one of my best 2026 trades. Good luck if you are still inside, now I will wait for a correction (in case it happens), but wouldn't be surprised if it goes straight to 105 or $125 before taking a deep break.
2
Dr_Stoxx
$TXG on the short list. Medtech play, ARK fave. Indicators lined up nicely for a bounce off the pullback. Just a bit too much downside momo however...will take a strong move to overcome.
1
CloudCapital
$TXG $80.66 | Strong Uptrend RSI 52.9 (Neutral) MACD Bullish | Vol 2.6x MA20 $80.39 | MA50 $66.53 MA200 $35.48 S $41.93 | R $102.81 Cap $10.51B P/E N/A | Fwd 1052.0 Moderate Outlook | $83.56 (+3.6%)
1
Afisyanadoh
$TXG sorry all. I bought 300 shares at 95$ yesterday. Totally my fault this has gone for shit today. Never fails. Fuk me gently with a sharp stick!
1
ccnau
$TXG From the summary of the last earnings report, see especially bullet point 2. Like Arnold, I'll be back!
1
WallStJesus
$TXG REPEAT BULL BETTING INTO STRENGTH THIS MORNING.. UPTICK IN BUYING OVER LAST WEEK AHEAD OF EARNINGS DUE 11/5
strassburg
$TXG Bought at $32. I should of sold in the $90S obviously. I got a little greedy. It just kept going up and up. I sold mid 70s. Still a profitable trade and I think this is a really cool company. I plan on re-entering when the dust settles. GLTA
bidenomics_man
$TXG bulls never listen, they always get fucked time and time again, it's just nature, there has to be losers for there to be winners, simply natural selection, the high iq bear wins and rapes the low iq bull to assert dominance
bidenomics_man
$TXG going back to $50 , you bulltards are delusional if you think all the buyers from the last 3 months are long-term, this is going to get violent for these low iq baggies, you all disgust me, I would spit on you if I saw you
topstockalerts
10x Genomics shares fell sharply, extending recent volatility as investors reassessed the stock’s elevated valuation following a major rally in life sciences tools. The decline came despite Canaccord Genuity raising its price target to $100 from $60 and maintaining a Buy rating, suggesting profit-taking near the $79.18 opening price. The stock has recently suffered declines of 13.4% on Oct. 6 and 6.2% on Oct. 8, after approaching its 52-week high of $102.81. Analyst sentiment remains cautious, with a consensus Hold rating, 11 of 18 analysts recommending Hold or Sell, and an average 12-month price target of $58.60. InvestingPro estimates fair value at $45.08, highlighting the valuation gap. Executives reportedly sold approximately $11.8 billion in shares last quarter without any recorded purchases, while the company remains unprofitable, with analysts forecasting an annual loss of $0.75 per share. $TXG
kevie6537
$TXG nothing but downside for awhile on these. All had massive runnups now it’s profit taking time….wait for bottom and consolidation. $TWST $TEM
bidenomics_man
$TXG thought shit was sweet and would just go up forever huh? Get fucked, welcome to the real world
manojaggarwal
$TXG I sold it all today around $85 ; this trade is done for now in my opinion; obviously I wish I sold at the top this morning but I still booked amazing profit ; cheers and on to the next play
Arcides
$TXG absolute puking on very high volume, the 3th highest daily volume in 1 year at this hour.

Advertisement|Remove ads.